Omega Healthcare Investors (NYSE:OHI) Releases FY 2024 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 2.840-2.860 for the period, compared to the consensus estimate of 2.830. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Berenberg Bank assumed coverage on shares of Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price objective for the company. Truist Financial boosted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. BNP Paribas upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective for the company in a research report on Thursday. Mizuho downgraded shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and upped their price target for the stock from $34.00 to $35.00 in a report on Thursday, July 25th. Finally, BMO Capital Markets upped their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a report on Monday, October 7th. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $39.70.

Omega Healthcare Investors Trading Down 3.0 %

Shares of Omega Healthcare Investors stock traded down $1.27 during trading on Friday, hitting $41.20. The company’s stock had a trading volume of 1,901,157 shares, compared to its average volume of 1,648,304. The company has a debt-to-equity ratio of 1.19, a current ratio of 5.79 and a quick ratio of 5.79. The stock has a market cap of $10.62 billion, a price-to-earnings ratio of 30.28, a price-to-earnings-growth ratio of 1.37 and a beta of 1.00. The stock has a 50-day moving average price of $40.47 and a two-hundred day moving average price of $35.96. Omega Healthcare Investors has a 52 week low of $27.53 and a 52 week high of $44.42.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). The firm had revenue of $252.70 million for the quarter, compared to the consensus estimate of $205.92 million. Omega Healthcare Investors had a net margin of 34.41% and a return on equity of 9.19%. The business’s revenue was up 17.5% compared to the same quarter last year. During the same period last year, the company posted $0.74 EPS. Equities research analysts anticipate that Omega Healthcare Investors will post 2.69 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be given a dividend of $0.67 per share. The ex-dividend date of this dividend is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.50%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 197.06%.

Insider Buying and Selling at Omega Healthcare Investors

In other news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at $4,025,000. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.